Neuroprotective potential of choline alfoscerate against β-amyloid injury: Involvement of neurotrophic signals

Cell Biol Int. 2020 Aug;44(8):1734-1744. doi: 10.1002/cbin.11369. Epub 2020 May 6.

Abstract

Alzheimer's disease represents the most prevalent neurodegeneration worldwide, clinically characterized by cognitive and memory impairment. New therapeutic approaches are extremely important to counteract this disorder. This research is focused on the potential use of choline alfoscerate in preventing neuronal death using in vitro models of Alzheimer's disease, representing the early stage of the disease, treated before or after the insult with glycerylphosphorylcholine. On the light of the results collected, we can postulate that choline alfoscerate, by the activation of the neurotrophin survival pathway, was able to counteract the detrimental effect of β-amyloid in both in vitro models, reducing apoptotic cell death and preserving the neuronal morphology.

Keywords: apoptosis; cerebrain; choline alfoscerate; neurodegeneration; neurotrophins; survival.

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / toxicity
  • Apoptosis / drug effects
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cell Differentiation
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Glycerylphosphorylcholine / pharmacology*
  • Humans
  • Neurons / cytology
  • Neurons / drug effects
  • Neuroprotective Agents / pharmacology*
  • Peptide Fragments / toxicity
  • Receptor, trkB / metabolism
  • Signal Transduction

Substances

  • Amyloid beta-Peptides
  • Brain-Derived Neurotrophic Factor
  • Neuroprotective Agents
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Glycerylphosphorylcholine
  • Receptor, trkB